Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (R01 AI142872, R01 AI172938, R21 AI151591, K24 AI106822)

This publication has 38 references indexed in Scilit: